PEDIATRICS Vol. 114 No. 4 October 2004, pp. 1175-1201 (doi:10.1542/10.1542/peds.2004-0809)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SUPPLEMENT ARTICLE |
Targeted Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection in Children and Adolescents
Pediatric Tuberculosis Collaborative Group
Comprehensive new guidelines for screening, targeted testing, and treating latent tuberculosis infection (LTBI) in children and adolescents are presented. The recent epidemiology of TB and data on risk factors for LTBI are reviewed. The evidence-based recommendations provided emphasize the paradigm that children and adolescents should be screened for risk factors by using a risk-factor questionnaire for TB and LTBI and tested with the tuberculin skin test only if 
1 risk factor is present. The use of administrative or mandated tuberculin skin tests for entry to day care, school, or summer camp is strongly discouraged. Treatment regimens, suggestions to improve adherence, and methods to monitor toxicities are summarized. Children and adolescents with LTBI represent the future reservoir for cases of TB. Thus, detecting and treating LTBI in children and adolescents will contribute to the elimination of TB in the United States.
Key Words: latent tuberculosis infection • tuberculin skin test • children • adolescents • pediatrics • tuberculosis
Abbreviations: TB, tuberculosis • LTBI, latent tuberculosis infection • USPHS, United States Public Health Service • CDC, Centers for Disease Control and Prevention • TST, tuberculin skin test • HIV, human immunodeficiency virus • AIDS, acquired immunodeficiency syndrome • AAP, American Academy of Pediatrics • TU, tuberculin units • PPD, purified protein derivative • MPT, multiple-puncture test • INH, isoniazid • DOT, directly observed therapy • MDR, multidrug-resistant • BCG, bacillus Calmette-Guérin • TNF-
, tumor necrosis factor • CT, computed tomography • DTH, delayed-type hypersensitivity • NTM, nontuberculous mycobacteria • ESAT-6, early secreted antigenic target 6 kDa • QFT, QuantiFERON-TB • IFN-
, interferon • ELISPOT, enzyme-linked immunospot • OR, odds ratio • CI95, 95% confidence interval
Accepted Jun 29, 2004.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  S. M. E. Finnell, J. C. Christenson, and S. M. Downs Latent Tuberculosis Infection in Children: A Call for Revised Treatment Guidelines Pediatrics, March 1, 2009; 123(3): 816 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Lobato, J. A. Jereb, and K. G. Castro Do We Have Evidence for Policy Changes in the Treatment of Children With Latent Tuberculosis Infection? Pediatrics, March 1, 2009; 123(3): 902 - 903. [Full Text] [PDF]
|
|
|
|
|
|
B. M. Bergamini, M. Losi, F. Vaienti, R. D'Amico, B. Meccugni, M. Meacci, D. De Giovanni, F. Rumpianesi, L. M. Fabbri, F. Balli, et al. Performance of Commercial Blood Tests for the Diagnosis of Latent Tuberculosis Infection in Children and Adolescents Pediatrics, March 1, 2009; 123(3): e419 - e424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kahn Evaluation of a Tuberculosis Skin Testing Program The Journal of School Nursing, February 1, 2009; 25(1): 48 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Trehan, J. K. Meinzen-Derr, L. Jamison, and M. A. Staat Tuberculosis Screening in Internationally Adopted Children: The Need for Initial and Repeat Testing Pediatrics, July 1, 2008; 122(1): e7 - e14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Lobato, J. A. Jereb, and J. R. Starke Unintended Consequences: Mandatory Tuberculin Skin Testing and Severe Isoniazid Hepatotoxicity Pediatrics, June 1, 2008; 121(6): e1732 - e1733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N. Lobato, S. J. Sun, P. K. Moonan, S. E. Weis, L. Saiman, A. A. Reichard, K. Feja, and for the Zero Tolerance for Pediatric TB Study Grou Underuse of Effective Measures to Prevent and Manage Pediatric Tuberculosis in the United States Arch Pediatr Adolesc Med, May 1, 2008; 162(5): 426 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Mayers and H. M. Adam Tuberculosis Pediatr. Rev., April 1, 2008; 29(4): 140 - 142. [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Rathore and A. Alvarez Is it Time to Revisit Short-Course Therapy for Latent TB Infection? AAP Grand Rounds, December 1, 2007; 18(6): 66 - 66. [Full Text] [PDF]
|
|
|
|
|
|
V. J. Flaherman, T. C. Porco, E. Marseille, and S. E. Royce Cost-effectiveness of Alternative Strategies for Tuberculosis Screening Before Kindergarten Entry Pediatrics, July 1, 2007; 120(1): 90 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Stout, K. K. Saharia, S. Nageswaran, A. Ahmed, and C. D. Hamilton Racial and Ethnic Disparities in Pediatric Tuberculosis in North Carolina Arch Pediatr Adolesc Med, June 1, 2006; 160(6): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Dewan, H. Banouvong, N. Abernethy, T. Hoynes, L. Diaz, M. Woldemariam, T. Ampie, J. Grinsdale, and L. M. Kawamura A Tuberculosis Outbreak in a Private-Home Family Child Care Center in San Francisco, 2002 to 2004 Pediatrics, March 1, 2006; 117(3): 863 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Jacono, M. A. O'Riordan, and L. Furman Can We Improve the Return Rate for Tuberculin Skin Test Readings? Arch Pediatr Adolesc Med, January 1, 2006; 160(1): 106 - 106. [Full Text] [PDF]
|
|
|
|
 |
|
 W. L. Risser and K. Connelly Smith Tuberculosis in Incarcerated Youth in Texas JAMA, June 8, 2005; 293(22): 2716 - 2717. [Full Text] [PDF]
|
|
|
|
|
|
H. M. Blumberg, M. K. Leonard Jr, and R. M. Jasmer Update on the Treatment of Tuberculosis and Latent Tuberculosis Infection JAMA, June 8, 2005; 293(22): 2776 - 2784. [Abstract] [Full Text] [PDF]
|
|
